After binding to its ligands, programmed death-ligand 1 (PD-L1), which is broadly expressed in healthy tissues and tumor cells, negatively regulates the effector functions of T cells, and promotes T-cell tolerance and escape from host immunity by downregulating CD8+ T-cell survival. Here, CD274 is linked to neoplasm.